A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy.
Primary ovarian signet-ring cell carcinoma is extremely rare, with only five recent case reports....
Read More
Hematology/Oncology
Ovarian cancer stem cells: ready for prime time?
The role of cancer stem cells (CSC) remains controversial and increasingly subject of...
Read More
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.
Immune checkpoint blocking antibodies are currently being tested in ovarian cancer (OC) patients...
Read More
Mechanism of inositol-requiring enzyme 1-alpha inhibition in endoplasmic reticulum stress and apoptosis in ovarian cancer cells.
IRE1α endonuclease is a key regulator of endoplasmic reticulum (ER) stress that controls cell...
Read More
Identification of an energy metabolism‑related gene signature in ovarian cancer prognosis.
Changes in energy metabolism may be potential biomarkers and therapeutic targets for cancer as...
Read More![[PARP INHIBITORS FOR ADJUVANT TREATMENT FOR OVARIAN CANCER].](https://cdn.physiciansweekly.com/wp-content/uploads/2023/08/woman-lady-obgyn-obstetrics-gynecology-627x376.jpg)
[PARP INHIBITORS FOR ADJUVANT TREATMENT FOR OVARIAN CANCER].
Treatment for ovarian cancer has been challenging for many years. It is composed of debulking...
Read More![[Vertigo as the first manifestation of ovarian cancer].](https://cdn.physiciansweekly.com/wp-content/uploads/2023/08/woman-lady-obgyn-obstetrics-gynecology-2-627x376.jpg)
[Vertigo as the first manifestation of ovarian cancer].
Vertigo is a common complaint and may rarely be the presenting symptom of a paraneoplastic...
Read More
lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
MIAT (myocardial infarction-associated transcript) regulates cell proliferation, apoptosis, and...
Read More
Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin.
The objectives of this study were to determine the sensitivity of ovarian cancer (OC) cell lines...
Read More
GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of and .
Although next-generation sequencing (NGS) is widely used for sequencing analysis, it involves a...
Read More
Parity as a Prognostic Factor in Patients with Advanced-Stage Epithelial Ovarian Cancer.
This study aimed to determine the prognostic factors influencing the overall survival (OS) of...
Read More
Tumor-derived exosomes in the regulation of macrophage polarization.
This review focuses on exosomes derived from various cancer cells. The review discusses the...
Read More
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial.
The GeparOcto randomized clinical trial compared the efficacy of 2 neoadjuvant breast cancer (BC)...
Read More
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
In recent decades, long non-coding RNAs (lncRNAs) have been reported as crucial functional...
Read More
Dietary fats promote inflammation in Wistar rats as well as induce proliferation, invasion of SKOV3 ovarian cancer cells.
The role of high fat diet (HFD) in ovarian cancer and its underlying mechanisms are poorly known....
Read More
CircRNA hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial-mesenchymal transition and apoptotic signaling pathways.
CircRNA plays an important role in the development of tumors, but its mechanism of action in...
Read More
KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors.
Few screening markers for malignant transformation in borderline ovarian tumors (BOT) have been...
Read More
Astragalus polysaccharides inhibits ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway.
Astragalus polysaccharide (APS), a natural anti-oxidant found in Astragalus membranaceus emerging...
Read More
Use of an Online Breast Cancer Risk Assessment and Patient Decision Aid in Primary Care Practices.
U.S. Preventive Services Task Force (USPSTF) recommendations for mammography screening, genetic...
Read More
Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study.
Late-onset lower limb lymphedema (LLL) is a significant clinical challenge for physicians dealing...
Read More